Insider Trading Alert - UnitedHealth Group And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Sept. 12, 2013, 127 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $200.00 to $1,099,500,000.00.

Highlighted Stocks Traded by Insiders:

UnitedHealth Group (UNH) - FREE Research Report

Leatherdale Douglas W who is Director at UnitedHealth Group sold 15,000 shares at $74.98 on Sept. 12, 2013. Following this transaction, the Director owned 912,879 shares meaning that the stake was reduced by 1.62% with the 15,000 share transaction.

The shares most recently traded at $75.14, up $0.16, or 0.21% since the insider transaction. Historical insider transactions for UnitedHealth Group go as follows:

  • 4-Week # shares bought: 1,000
  • 4-Week # shares sold: 15,000
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 125,000
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 154,866

The average volume for UnitedHealth Group has been 4.4 million shares per day over the past 30 days. UnitedHealth Group has a market cap of $76.4 billion and is part of the health care sector and health services industry. Shares are up 38.61% year to date as of the close of trading on Thursday.

UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The stock currently has a dividend yield of 1.49%. The company has a P/E ratio of 14.3. Currently there are 15 analysts that rate UnitedHealth Group a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UNH - FREE

TheStreet Quant Ratings rates UnitedHealth Group as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full UnitedHealth Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Tenet Healthcare Is 'Heavily Indebted,' Jim Cramer Warns

Cramer: Market Rushes to Refill Its Glass

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Boeing, Pure Storage, Activision Blizzard: 'Mad Money' Lightning Round

The Makings of Another Huge Rebound?